While these medications provide promising results, they also carry potential side effects, such as gastrointestinal discomfort and a rare risk of pancreatitis
Lets Connect Have questions about GLP-1 or oral drops before getting started
But for researchers who want deeper protocol support, SeekPeptides members access personalized protocol builders, detailed weight-based dosing guides, and expert-reviewed titration schedules that account for individual factors like body weight, tolerance, and goals
The FDA-approved injectable form (Zepbound) has been studied in large clinical trials and shown to produce significant, sustained weight loss
Tirzepatide is a dual GLP-1/GIP receptor agonist, activating both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors simultaneously